MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders.

B Delaval, H Lelièvre, D Birnbaum, Myeloproliferative disorders: the centrosome connection. Leukemia. ,vol. 19, pp. 1739- 1744 ,(2005) , 10.1038/SJ.LEU.2403926

Catherine Lacout, Didier F. Pisani, Micheline Tulliez, Françoise Moreau Gachelin, William Vainchenker, Jean-Luc Villeval, JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis Blood. ,vol. 108, pp. 1652- 1660 ,(2006) , 10.1182/BLOOD-2006-02-002030

C James, F Delhommeau, C Marzac, I Teyssandier, J-P Le Couédic, S Giraudier, L Roy, P Saulnier, L Lacroix, S Maury, M Tulliez, W Vainchenker, V Ugo, N Casadevall, Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia. ,vol. 20, pp. 350- 353 ,(2006) , 10.1038/SJ.LEU.2404069

Jing-Yi Shi, Zhan-Zhong Shi, Su-Jiang Zhang, Yong-Mei Zhu, Bai-Wei Gu, Guo Li, Xue-Tao Bai, Xiao-Dong Gao, Jiong Hu, Wei Jin, Wei Huang, Zhu Chen, Sai-Juan Chen, Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics. ,vol. 14, pp. 759- 768 ,(2004) , 10.1097/00008571-200411000-00007

Martin Sattler, Christoph Walz, Brian J. Crowley, Eva Lengfelder, Pasi A. Jänne, Andrew M. Rogers, Yanan Kuang, Robert J. Distel, Andreas Reiter, James D. Griffin, A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples. Blood. ,vol. 107, pp. 1237- 1238 ,(2006) , 10.1182/BLOOD-2005-07-2899

Amy V Jones, Sebastian Kreil, Katerina Zoi, Katherine Waghorn, Claire Curtis, Lingyan Zhang, Joannah Score, Rachel Seear, Andrew J Chase, Francis H Grand, Helen White, Christine Zoi, Dimitris Loukopoulos, Evangelos Terpos, Elisavet-Christine Vervessou, Beate Schultheis, Michael Emig, Thomas Ernst, Eva Lengfelder, Rüdiger Hehlmann, Andreas Hochhaus, David Oscier, Richard T Silver, Andreas Reiter, Nicholas CP Cross, Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders Blood. ,vol. 106, pp. 2162- 2168 ,(2005) , 10.1182/BLOOD-2005-03-1320

Roberto H Nussenzveig, Sabina I Swierczek, Jaroslav Jelinek, Amos Gaikwad, Enli Liu, Srdan Verstovsek, Jaroslav F Prchal, Josef T Prchal, None, Polycythemia vera is not initiated by JAK2V617F mutation Experimental Hematology. ,vol. 35, pp. 32.e1- 32.e9 ,(2007) , 10.1016/J.EXPHEM.2006.11.012

Peter J Campbell, Linda M Scott, Georgina Buck, Keith Wheatley, Clare L East, Joanne T Marsden, Audrey Duffy, Elaine M Boyd, Anthony J Bench, Mike A Scott, George S Vassiliou, Donald W Milligan, Steve R Smith, Wendy N Erber, David Bareford, Bridget S Wilkins, John T Reilly, Claire N Harrison, Anthony R Green, None, Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study The Lancet. ,vol. 366, pp. 1945- 1953 ,(2005) , 10.1016/S0140-6736(05)67785-9